by Jinghong Chen
As the Trump administration pushes to accelerate the use of artificial intelligence across federal programs, CMS is preparing to roll out a first-of-its-kind AI-backed prior authorization model in traditional Medicare — but industry experts warn it could be a bumpy road.
The Wasteful and Inappropriate Service Reduction (WISeR) model, announced in June, will use AI for prior authorization on select services, including skin and tissue substitutes, implantation of electrical nerve stimulators and knee arthroscopy for knee osteoarthritis. The model is set to launch in January and run through 2031 in six states: New Jersey, Ohio, Oklahoma, Texas, Arizona and Washington.
“CMS is committed to crushing fraud, waste, and abuse, and the WISeR Model will help root out waste in Original Medicare,” CMS Administrator Mehmet Oz, M.D., said in a press release.
In November, CMS named six private health technology companies to administer the model:
Genzeon Corp. (New Jersey): The health care AI and automation company partners with over 75 payer, provider and healthtech clients, offering AI-powered services and platform solutions, according to the company.
Innovaccer Inc. (Ohio): The Silicon Valley-based digital health care company currently offers technology to CommonSpirit Health and Banner Health. This year, it announced a collaboration with California’s Sacramento County Department of Health Services to support Medi-Cal and justice-involved populations. The company spent $60,000 in the first half of 2025 lobbying on AI in health care.
Humata Health, Inc. (Oklahoma): The physician-led health care technology company was founded in 2023 and is backed by investors, including Blue Venture Fund, LRVHealth, 406 Ventures and Highmark Ventures. The company said in a statement that its technology “approves requests immediately, but can never deny them; complex cases that are not an instant ‘yes’ must go to a human clinician for review.”
Cohere Health, Inc. (Texas): The clinical intelligence firm processes over 12 million prior authorization requests annually and works with more than 560,000 providers across the nation, according to the firm. It partners with health plans including Humana Inc., Geisinger Health Plan and Medical Mutual in Ohio on utilization management. The company spent $150,000 in the first three quarters of 2025 lobbying on federal AI policy, the Senate Office of Public Records shows.
Zyter Inc. (Arizona): The privately held digital health product organization currently serves 45 health plans and covers over 44 million lives, according to the company. In 2020, it received over 50 awards including Company Innovation of the Year and Best Health Care and Medical Innovation, according to Crunchbase.
Virtix Health LLC (Washington): The Arizona-based health care technology company focuses on clinical data acquisition, quality reporting and risk-adjustment coding services. It has digital and credentialed access to over 80,000 site locations, according to a company LinkedIn post.
Under WISeR, these selected companies will receive a percentage of the savings based on their ability to reduce unnecessary services and spending.
CMS also stressed that clinicians must be involved throughout the process, and the final decisions will be made by licensed clinicians, not machines. The model excludes inpatient-only services, emergency services and treatments that would pose a significant risk to patients if delayed.
Still, industry experts warn that WISeR could magnify ongoing concerns about delays and denials in medical care.
“My first concern centers around delaying necessary care to Medicare beneficiaries, followed closely by the nonspecific denial reasons typically given,” AArete managing director Pam Price tells Payer Perspectives. “Not understanding why the request was denied adds more care delays and complexity to resubmit or obtain a peer review determination.”
Avalere managing director Mark Newsom, who previously served as deputy group director at CMS, notes that AI tools like ChatGPT have a significant error rate and often struggle to distinguish high-quality information from unreliable sources. And it remains unclear what training data set is being used and how different stakeholders using AI will be held accountable for accuracy.
Appeals and litigations are likely, he says. “The agency is going to have to figure out, how do they build in quality assurance and appeals processes…that deal with results that are inaccurate.”
“I think they’d be wise to be transparent about how that process works out,” so the public can fairly assess whether WISeR meets its goals, Newsom adds.
While some provider groups argued that prior authorization was not used in fee-for-service Medicare, Newsom says such a claim is inaccurate. “There has been prior authorization by that name or other names before in fee-for-service, most notably home health,” he adds.
Newsom points to prior authorization requirements CMS adopted in 2020 for certain hospital outpatient department procedures such as blepharoplasty, botulinum toxin injections, panniculectomy, rhinoplasty and vein ablation, as well as the Repetitive, Scheduled Non-Emergent Ambulance Transport model launched in 2014 and later expanded nationwide.
Action Plan: Administration Aims to ‘Establish American AI’
The same week CMS named the six vendors it selected for the WISeR model, House Democrats moved to repeal the initiative entirely, introducing the Seniors Deserve SMARTER Care Act of 2025.
“We know that prior authorization in Medicare Advantage and elsewhere ultimately limits access to care, increases the burden on loved ones and care providers and leads to worse health outcomes,” Rep. Suzan DelBene (D-Wash.) said in a joint statement with her co-sponsors. Washington is among the six states where WISeR will first take effect.
DelBene is also one of the 17 lawmakers who wrote to Oz in August seeking details on how CMS will select the entities conducting prior authorization and what safeguards it will impose to avoid inappropriate denials.
The growing political pressure comes at a time when AI-driven prior authorization is already under scrutiny in Medicare Advantage. The nation’s largest Medicare insurer, UnitedHealthcare, is facing a class action lawsuit over its use of AI to deny claims for post-acute care in MA plans. Cigna Healthcare and Humana both have also been sued for allegedly using AI algorithms to deny care.
Yet Newsom notes that “this administration has been very clear they want to see AI used more everywhere.”
In July, the Trump administration released America’s AI Action Plan, which calls on agencies to accelerate AI innovation and reduce “unnecessary regulatory barriers that hinder the private sector.” More recently, President Donald Trump publicly criticized states for overregulating AI and called for a single federal standard.
According to CNBC, the administration has drafted an executive order directing Attorney General Pam Bondi to establish an “AI Litigation Task Force” that would challenge state AI regulations “on grounds that such laws unconstitutionally regulate interstate commerce, are preempted by existing Federal regulations, or are otherwise unlawful in the Attorney General’s judgment.”
At least 29 states and Washington D.C. have passed at least one bill addressing the use of AI in health care, as of August 2025, according to an Avalere Health analysis co-authored by Newsom. Many of the states limit the extent to which a plan can use this technology in claims or prior authorization reviews.
With WISeR now moving toward implementation, Newsom says he anticipates that stakeholders will leverage the outcome to push their advocacy agenda in broader policy debates. “I think there’s going to be a lot of pushback and going to be a lot of people monitoring this very closely, so [CMS] needs to get it right.”
‘AI-on-AI Warfare’ Rages in Health Care
Big AI firms have been flooding Capitol Hill with tens of millions of lobbying dollars to shape federal policy. In the third quarter of 2025, OpenAI spent $920,000 on lobbying, more than double its spending from the same period a year ago, the Senate Office of Public Records shows. Anthropic, the startup behind Claude, dropped over $1 million on lobbying in the third quarter, bringing its total for the year to nearly $2.3 million.
By the third quarter, more than 150 different entities had lobbied on AI policy in health care, including major trade groups such as the American Medical Association and Pharmaceutical Research and Manufacturers of America.
Newsom notes that large language models and other AI tools are rapidly expanding across the health care industry, where providers and revenue cycle management companies are using AI for billing and health plans are deploying it for prior authorization and billing review.
“I’ve jokingly called that Autobots vs. Decepticons. We got an AI-on-AI warfare going on in the health care space,” he says.

